A majority of the brokerage firms are positive on the issue and suggest investors subscribe to the issue on a long-term basis but some analysts have raised red flags over rich valuations and the complete OFS nature.
The IPO of Mankind Pharma was off the mark on Tuesday but the issue saw a muted response from the investors during the initial two hours of the book-building process.
Mankind Pharma IPO: Manforce Condoms and Prega News manufacturer Mankind Pharma s IPO will open for subscription today and close on April 27. Watch this Business Today Visual Story for IPO details.
A majority of the brokerage firms are positive on the issue and suggest investors subscribe to the issue on a long-term basis, but some analysts have raised red flags over rich valuations and complete OFS nature.